UK markets close in 7 hours 27 minutes

Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.05750.0000 (0.00%)
At close: 01:37PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 679.74M
Enterprise value 234.63M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.08
Price/book (mrq)0.88
Enterprise value/revenue 0.13
Enterprise value/EBITDA 0.70

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3-39.47%
S&P500 52-week change 323.57%
52-week high 30.1200
52-week low 30.0450
50-day moving average 30.0533
200-day moving average 30.0779

Share statistics

Avg vol (3-month) 39
Avg vol (10-day) 330
Shares outstanding 59.33B
Implied shares outstanding 611.82B
Float 83.95B
% held by insiders 155.03%
% held by institutions 14.96%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 48.44%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 430.34%
Dividend date 3N/A
Ex-dividend date 407 Jun 2023
Last split factor 22:1
Last split date 305 Jun 2014

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -2.90%
Operating margin (ttm)-24.98%

Management effectiveness

Return on assets (ttm)-0.74%
Return on equity (ttm)-4.78%

Income statement

Revenue (ttm)1.86B
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 40.21M
Net income avi to common (ttm)-54.02M
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.37B
Total cash per share (mrq)0.47
Total debt (mrq)1.25B
Total debt/equity (mrq)24.36%
Current ratio (mrq)1.51
Book value per share (mrq)0.48

Cash flow statement

Operating cash flow (ttm)199.49M
Levered free cash flow (ttm)1.33B